(Total Views: 501)
Posted On: 09/25/2025 3:25:35 PM
Post# of 157259
Re: KenChowder #157131
I have hardly posted on this board at all, though I have greatly benefited from the knowledge of yourself, homes, Katanga, low,I have hardly posted on this board at all, though I have greatly benefited from the knowledge of yourself, Ohm, Katangalo and too many others to list.
I have held the stock for more than 12 years. I think the leronlimab molecule is phenomenal.
However I agree with your statement about the Hoffman presentation not being well done. In fact it was lousy. He sat at a desk with his back turned to the audience much of the time and read off the slides, commenting once that he needed glasses - in fact he should have been familiar enough with the material that he could have made the presentation blinded. When he came to the most important points about the survivors of mTNBC he just read off P-F-S and O-S without explaining what those initials stood for and how remarkable it was that these ladies were alive at 5 years and what that portends for the mechanism of action and the future of the treatment of solid tumors. He mispronounced the name of our CEO leaving out a syllable as well as garbling the name of Lataillade. I don't know what his audience was or how many people were in attendance, but I give him an "F" for the presentation. He probably has a lot more shares than me having just come on board.We need better and I hope Pestell is outstanding at the AACR this coming weekend.
GLTAL
I have held the stock for more than 12 years. I think the leronlimab molecule is phenomenal.
However I agree with your statement about the Hoffman presentation not being well done. In fact it was lousy. He sat at a desk with his back turned to the audience much of the time and read off the slides, commenting once that he needed glasses - in fact he should have been familiar enough with the material that he could have made the presentation blinded. When he came to the most important points about the survivors of mTNBC he just read off P-F-S and O-S without explaining what those initials stood for and how remarkable it was that these ladies were alive at 5 years and what that portends for the mechanism of action and the future of the treatment of solid tumors. He mispronounced the name of our CEO leaving out a syllable as well as garbling the name of Lataillade. I don't know what his audience was or how many people were in attendance, but I give him an "F" for the presentation. He probably has a lot more shares than me having just come on board.We need better and I hope Pestell is outstanding at the AACR this coming weekend.
GLTAL
(19)
(0)
